Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 16/20 | 0.44 |
| ▸ | CNR1 | P21554 | 10/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL340854 | 0.89 | MEN1 (0.44) | CNR2CNR1KDM4EMEN1ALDH1A1 | |
| SCHEMBL124487 | 0.87 | THRB (0.50) | THRBTSHRCNR2CNR1KDM4E | |
| SCHEMBL126069 | 0.86 | THRB (0.47) | THRBCNR2CNR1KDM4EMEN1 | |
| SCHEMBL20740546 | 0.85 | THRB (0.48) | THRBTSHRCNR2CNR1KDM4E | |
| SCHEMBL2859161 | 0.83 | THRB (0.56) | THRBTSHRCNR2CNR1KDM4E | |
| SCHEMBL29413087 | 0.83 | THRB (0.50) | THRBTSHRCNR2CNR1KDM4E | |
| SCHEMBL2859639 | 0.81 | THRB (0.53) | THRBCNR2CNR1KDM4EMEN1 | |
| SCHEMBL2868709 | 0.81 | THRB (0.53) | THRBTSHRCNR2CNR1KDM4E | |
| SCHEMBL9106113 | 0.80 | THRB (0.53) | THRBTSHRCNR2CNR1KDM4E | |
| Isosulfan Blue Inner Salt SCHEMBL3324345 | 0.79 | MEN1 (0.44) | CNR2CNR1KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0743523-B1 | Dye-based reference material, preparation and use thereof | BAYER AG (US) | 2002-08-28 | — | — | EP | claimed |
| CN-119371904-A | Multilayer explosion-proof nano film and manufacturing method thereof | 南通通易航天科技股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118498103-A | Spandex composite coated yarn and preparation process thereof | 杭州惠丰化纤有限公司 | 2024-08-16 | — | — | CN | disclosed |
| WO-2022188373-A1 | METHOD FOR DETECTING WATER-SOLUBLE ANIONIC SYNTHETIC PIGMENT IN FOOD | 广州市食品检验所（广州市酒类检测中心） | 2022-09-15 | — | — | WO | disclosed |
| EP-2710996-B1 | Sunscreen compositions comprising colour pigments | BASF SE (DE) | 2022-08-17 | — | — | EP | disclosed |
| US-11384033-B2 | Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants | BASF SE (DE) | 2022-07-12 | — | — | US | disclosed |
| CN-107108388-B | Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect | 巴斯夫欧洲公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-112374933-A | Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect | 巴斯夫欧洲公司 | 2021-02-19 | — | — | CN | disclosed |
| EP-3763691-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| EP-3763692-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO) PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| US-7651661-B2 | Medical devices with broad spectrum antimicrobial activity | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-01-26 | — | — | US | disclosed |
| EP-1663138-B1 | DYE COMPOSITION AND METHOD FOR DETECTION OF DEMINERALIZED LESIONS IN TEETH | PROCTER & GAMBLE (US) | 2008-11-26 | — | — | EP | disclosed |
| US-20080183152-A1 | MEDICAL DEVICES WITH BROAD SPECTRUM ANTIMICROBIAL ACTIVITY | RAAD ISSAM | 2008-07-31 | — | — | US | disclosed |
| US-20070154621-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2007-07-05 | — | — | US | disclosed |
| CN-1842319-A | Dye composition and method for examining tooth demineralization damage | PROCTER & GAMBLE (US) | 2006-10-04 | — | — | CN | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| US-20050058602-A1 | Dye composition and method for detection of demineralized lesions in teeth | THE PROCTER & GAMBLE COMPANY | 2005-03-17 | — | — | US | disclosed |
| WO-2003089559-A1 | BLUE COLORED LIQUID CRYSTAL COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| US-6475975-B1 | Blue colored liquid crystal compositions | COLGATE-PALMOLIVE COMPANY | 2002-11-05 | — | — | US | disclosed |
| WO-1994009360-A1 | ASSAY FOR CATIONIC SURFACTANTS | CTS BIOCIDES LTD. (GB) | 1994-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384033-B2 | Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants | SLC14A1, XDH, PNP | THRB 972/4885TSHR 652/4885CNR2 2236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.